Topas Therapeutics will be translational partner for CRC focused on liver inflammation

Topas Therapeutics, a German-based platform company, will serve as the exclusive translational partner for the recently extended Collaborative Research Center (CRC) 841, ‘Liver inflammation: infection, immune regulation and consequences’. more

25 Jan 2018 12:28 News